Abhay Singh

Hypomethylating agents (HMA) treatment for myelodysplastic syndromes: alternatives in the frontline and relapse settings

S. Gore, T. Prebet, N. Uy, 2017, Expert opinion on pharmacotherapy.

Predictors of vascular disease in myelodysplastic syndromes

S. Thota, E. Wang, E. Griffiths, 2020, EJHaem.

Outcomes of Adult Acute Myeloid Leukemia Treated With Gemtuzumab-Ozogamicin: Cue To Optimized Chemotherapy Backbone.

K. Attwood, S. Thota, E. Wang, 2021, Clinical lymphoma, myeloma & leukemia.

From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?

S. Halene, J. Bewersdorf, A. Zeidan, 2019, Blood reviews.

Eosinophilia characterized by a rare CCT6B mutation and responsive to tyrosine kinase inhibition: Case report and literature review

E. Wang, J. Baron, Abhay Singh, 2021, Leukemia research reports.